Skip to main content
Log in

Cadherin Junctions in Mammary Tumors

  • Published:
Journal of Mammary Gland Biology and Neoplasia Aims and scope Submit manuscript

Abstract

Cadherins are the transmembrane component of adherens junctions found between interacting cells in tissues. The cadherins bind cells to one another in a specific manner and link to the actin cytoskeleton through intracellular catenins. In addition to promoting strong cell-cell adhesion, cadherins appear to initiate and modify intracellular signaling pathways. The loss of E-cadherin function in epithelial cells is thought to be an important step in tumorigenesis. Moreover, anomalous expression of inappropriate cadherins in epithelial cells alters their behavior and may contribute to the tumorigenic phenotype. For breast cancer the decreased expression of E-cadherin alone may have limited value as a prognostic indicator; however, examining the repertoire of cadherins and catenins expressed by tumors may provide useful prognostic information.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. M. Takeichi (1990). Cadherins: A molecular family important in selective cell-cell adhesion. Annu. Rev. Biochem. 59:237-252.

    PubMed  Google Scholar 

  2. O. W. Blaschuk, S. Munro, and R. Farookhi (1995). Cadherins, steroids and cancer. Endocrine 3:83-89.

    Google Scholar 

  3. M. J. Wheelock, K. A. Knudsen, and K. R. Johnson (1996). Membrane-cytoskeleton interactions with cadherin cell adhesion proteins; roles of catenins as linker proteins. Current Topics in Membranes 43:169-185.

    Google Scholar 

  4. K. A. Knudsen, C. Frankowsky, K. R. Johnson, and M. J. Wheelock (1998). A role for cadherins in cellular signaling and differentiation. J. Cell. Biochem. S 30/31:168-176.

    Google Scholar 

  5. K. R. Johnson, M. J. Wheelock, and M. Takeichi (1999). Cadherins. In T. Kreis and R. Vale (eds.), Guidebook to the Extracellular Matrix, Anchor, and Adhesion Proteins, Oxford University Press, Oxford, pp. 141-149.

    Google Scholar 

  6. W.-S. Shan, H. Tanaka, G. R. Phillips, K. Arndt, M. Yoshida, D. R. Colman, and L. Shapiro (2000). Functional cisheterodimers of N-and R-cadherins. J. Cell Biol. 148:579-590.

    PubMed  Google Scholar 

  7. F. S. Walsh and P. Doherty (1997). Neural cell adhesion molecules of the immunoglobulin super family: Role in axonal growth and guidance. Annu. Rev. Cell Biol. 13:425-456.

    Google Scholar 

  8. M. T. Nieman, R. S. Prudoff, K. R. Johnson, and M. J. Wheelock (1999). N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell Biol. 147:631-643.

    PubMed  Google Scholar 

  9. R. B. Hazan, G. R. Phillips, R. F. Qiao, L. Norton, and S. A. Aaronson (2000). Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol. 148:779-790.

    PubMed  Google Scholar 

  10. J. K. Wahl., P. A. Sacco, T. M. McGranahan, L. Sauppé, M. J. Wheelock, and K. R. Johnson (1996). Plakoglobin domains that define its association with the desmosomal cadherins and the classical cadherins: Identification of unique and shared domains. J. Cell Sci. 109:1043-1054.

    Google Scholar 

  11. J. E. Nieset, A. R. Redfield, F. Jin, K. A. Knudsen, K. R. Johnson, and M. J. Wheelock (1997). Characterization of the interactions of α-catenin with α-actinin and βcatenin/ plakoglobin. J. Cell Sci. 110:1013-1022.

    PubMed  Google Scholar 

  12. J. M. Daniel, and A. B. Reynolds (1997). Tyrosine phosphorylation and cadherin/catenin function. BioEssays 19:883-891.

    PubMed  Google Scholar 

  13. J. R. Miller, A. M. Hocking, J. D. Brown, and R. T. Moon (1999). Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2C pathways. Oncogene 18:7860-7872.

    PubMed  Google Scholar 

  14. K. M. Cadigan and R. Nusse (1997). Wnt signaling: A common theme in animal development. Genes Dev. 11:3286-3305.

    PubMed  Google Scholar 

  15. P. Polakis, M. Hart, and B. Rubinfeld (1999). Defects in the regulation of beta-catenin in colorectal cancer. Adv. Exp. Med. Biol. 470:23-32.

    PubMed  Google Scholar 

  16. P. J. Morin. β-catenin signaling and cancer (1999). BioEssays 21:1021-1030.

    PubMed  Google Scholar 

  17. S. Aono, S. Nakagawa, A. B. Reynolds, and M. Takeichi (1999). p120(ctn) acts as an inhibitory regulator of cadherin function in colon carcinoma cells. J. Cell Biol. 145:551-562.

    PubMed  Google Scholar 

  18. T. Ohkubo and M. Ozawa (1999). p120(ctn) binds to the membrane-proximal region of the E-cadherin cytoplasmic domain and is involved in modulation of adhesion activity. J. Biol. Chem. 274:21409-21415.

    PubMed  Google Scholar 

  19. M. A. Thoreson, P. Z. Anastasiadis, J. M. Daniel, R. C. Ireton, M. J. Wheelock, K. R. Johnson, D. K. Hummingbird, and A. B. Reynolds (2000). Selective uncoupling of p120(ctn) from Ecadherin disrupts strong adhesion. J. Cell Biol. 148:189-202.

    PubMed  Google Scholar 

  20. P. Z. Anastasiadis, S. Y. Moon, M. A. Thoreson, D. J. Mariner, H. C. Crawford, Y. Zheng, and A. B. Reynolds (2000). Inhibition of RhoA by p120 catenin. Nat. Cell Biol. 9:637-644.

    Google Scholar 

  21. N. K. Noren, B. P. Liu, K. Burridge, and B. Kreft (2000). p120 catenin regulates the actin cytoskeleton via Rho family GTPases. J. Cell Biol. 150:567-580.

    PubMed  Google Scholar 

  22. S. M. Brady-Kalnay and N. K. Tonks (1995). Protein tyrosine phosphatases as adhesion receptors. Curr. Opin. Cell Biol. 7:650-657.

    PubMed  Google Scholar 

  23. P. Guilford (1999). E-cadherin down-regulation in cancer: Fuel on the fire? Molecular Medicine Today 5:172-177.

    PubMed  Google Scholar 

  24. J. Behrens (1999). Cadherins and catenins: Role in signal transduction and tumor progression. Cancer and Metastasis Reviews 18:15-30.

    PubMed  Google Scholar 

  25. M. A. El-Bahrawy, and M. Pignatelli (1998). E-cadherin and catenins: Molecules with versatile roles in normal and neoplastic epithelial cell biology. Microscopy Research and Technique 43:224-232.

    PubMed  Google Scholar 

  26. A.-K. Perl, P. Wilgenbus, U. Dahl, H. Semb, and G. Christofori (1998). A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392:190-193.

    PubMed  Google Scholar 

  27. G. Berx, K.-F. Becker, H. Höfler, and F. van Roy (1998). Mutations of the human E-cadherin (CDH1) gene. Human Mutation 12:226-237.

    PubMed  Google Scholar 

  28. F. Nollet, G., Berx, and F. van Roy (1999). The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. Mol. Bell Biol. Res. Comm. 2:77-85.

    Google Scholar 

  29. M. J. Pishvaian, C. M. Feltes, P. Thompson, M. J. Bussemakers, J. A. Schalken, and S. W. Byers (1999). Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res. 59:947-952.

    PubMed  Google Scholar 

  30. S. Islam, T. E. Carey, G. T. Wolf, M. J. Wheelock, and K. R. Johnson (1996). Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J. Cell Biol. 135:1643-1654.

    PubMed  Google Scholar 

  31. J.-B. Kim, S. Islam, Y. J. Kim, R. S. Prudoff, K. M. Sass, M. J. Wheelock, and K. R. Johnson (2000). N-cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J. Cell Biol. 151:1193-1205.

    PubMed  Google Scholar 

  32. A. Peralta Soler, K. A. Knudsen, M.-C. Jaurand, K. R. Johnson, M. J. Wheelock, A. J. P. Klein-Szanto, and H. Salazar (1995). The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas. Human Pathology 26:1363-1369.

    PubMed  Google Scholar 

  33. R. B. Hazan, L. Kang, B. P. Whooley, and P. I. Borgen (1997). N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes. Commun. 4:399-411.

    PubMed  Google Scholar 

  34. A. S. T. Wong, S. L. Maines-Bandiera, B. Rosen, M. J. Wheelock, K. R. Johnson, P. C. K. Leung, C. D. Roskelley, and N. Auersperg (1999). Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: Influence of family history of ovarian cancer. Int. J. Cancer 81:180-188.

    PubMed  Google Scholar 

  35. M. Katayama, S. Hirai, K. Kamihagi, K. Nakagawa, M. Yasumoto, and I. Kato (1994). Soluble E-cadherin fragments increased in circulation of cancer patients. Br. J. Cancer 69:580-585.

    PubMed  Google Scholar 

  36. K. A. Knudsen, Y. L. Chen, K. R. Johnson, M. J. Wheelock, A. A. Keshgegian, and A. Peralta Soler (2000). Lack of correlation between serum levels of E-and P-cadherin fragments and the presence of breast cancer. Human Pathology 31:961-965.

    PubMed  Google Scholar 

  37. S. Shirahama, F. Furukawa, H. Wakita, and M. Takigawa (1996). E-and P-cadherin expression in tumor tissues and soluble E-cadherin levels in sera of patients with skin cancer. J. Dermatol. Sci. 13:30-36.

    PubMed  Google Scholar 

  38. S. Hiraguri, T. Godfrey, H. Nakamura, J. Graff, C. Collins, L. Shayesteh, N. Doggett, K. R. Johnson, M. J. Wheelock, J. Herman, S. Baylin, D. Pinkel, and J. Gray (1998). Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Res. 58:1972-1977.

    PubMed  Google Scholar 

  39. G. Hennig, J. Behrens, M. Truss, S. Frisch, E. Reichmann, and W. Birchmeier (1995). Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 11:475-484.

    PubMed  Google Scholar 

  40. G. Mbalaviele, C. R. Dunstan, A. Sasaki, P. J. Williams, G. R. Mundy, and T. Yoneda (1996). E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res. 56:4063-4070.

    PubMed  Google Scholar 

  41. S. Meiners, V. Brinkmann, H. Naundorf, and W. Birchmeier (1998). Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene 16:9-20.

    PubMed  Google Scholar 

  42. M. E. Bracke, C. Charlier, E. A. Bruyneel, C. Labit, M. M. Mareel, and V. Castronovo (1994). Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. Cancer Res. 54:4607-4609.

    PubMed  Google Scholar 

  43. S. Z. Yang, N. Kohno, K. Kondo, A. Yokoyama, H. Hamada, K. Hiwada, and M. Miyake (1999). Adriamycin activates Ecadherin-mediated cell-cell adhesion in human breast cancer cells. Int. J. Oncol. 15:1109-1115.

    PubMed  Google Scholar 

  44. M. E. Bracke, B. M. Vyncke, E. A. Bruyneel, S. J. Vermeulen, G. K. De Bruyne, N. A. Van Larebeke, K. Vleminckx, F. M. Van Roy, and M. M. Mareel (1993). Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro. Br. J. Cancer. 68:282-289.

    PubMed  Google Scholar 

  45. Q. Meng, B. Gao, I. D. Goldberg, E. M. Rosen, and S. Fan (2000). Stimulation of cell invasion and migration by alcohol in breast cancer cells. Biochem. Biophys. Res. Commun. 273:448-453.

    PubMed  Google Scholar 

  46. R. Moll, M. Mitze, U. H. Frixen, and W. Birchmeier (1993). Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am. J. Pathol. 143:1731-1742.

    PubMed  Google Scholar 

  47. C. Gamallo, J. Palacios, A. Suarez, A. Pizarro, P. Navarro, M. Quintanilla, and A. Cano (1993). Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am. J. Pathol. 142:987-993.

    PubMed  Google Scholar 

  48. S. A. Rasbridge, C. E. Gillett, S. A. Sampson, F. S. Walsh, and R. R. Millis (1993). Epithelial (E-) and Placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J. Pathol. 169:245-250.

    PubMed  Google Scholar 

  49. S. M. Siitonen, J. T. Kononen, H. J. Helin, I. S. Rantala, K. A. Holli, and J. J. Isola (1996). Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am. J. Clin. Pathol. 105:394-402.

    PubMed  Google Scholar 

  50. W. J. De Leeuw, G. Berx, C. B. Vos, J. L. Peterse, M. J. Van de Vijver, S. Litvinov, F. Van Roy, C. J. Cornelisse, and A. M. Cleton-Jansen (1997). Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J. Pathol. 183:404-411.

    PubMed  Google Scholar 

  51. C. B. Vos, A. M. Cleton-Jansen, G. Berx, W. J. de Leeuw, N. T. ter Haar, F. van Roy, C. J. Cornelisse, J. L. Peterse, and M. J. van de Vijver (1997). E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br. J. Cancer 76:1131-1133.

    PubMed  Google Scholar 

  52. G. Keller, H. Vogelsang, I. Becker, J. Hutter, K. Ott, S. Candidus, T. Grundei, K. F. Becker, J. Mueller, J. R. Siewert, and H. Hofler (1999). Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am. J. Pathol. 155:337-342.

    PubMed  Google Scholar 

  53. R. Hashizume, H. Koizumi, A. Ihara, T. Ohta, and T. Uchikoshi (1996). Expression of β-catenin in normal breast tissue and breast carcinoma: A comparative study with epithelial cadherin and β-catenin. Histopathology 29:139-146.

    PubMed  Google Scholar 

  54. A. Peralta Soler, K. A. Knudsen, H. Salazar, A. C. Han, and A. A. Keshgegian (1999). P-cadherin expression in breast carcinoma indicates poor survival. Cancer 86:1263-1272.

    PubMed  Google Scholar 

  55. H. Oka, H. Shiozaki, K. Kobayashi, M. Inoue, H. Tahara, T. Kobayashi, Y. Takatsuka, N. Matsuyoshi, S. Hirano, M. Takeichi, and T. Mori (1993). Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res. 53:1696-1701.

    PubMed  Google Scholar 

  56. S. K. Gupta, A. G. Douglas-Jones, B. Jasani, J. M. Morgan, M. Pignatelli, and R. E. Mansel (1997). E-cadherin (E-cad) expression in duct carcinoma in situ (DCIS) of the breast. Virchows Arch. 430:23-28.

    PubMed  Google Scholar 

  57. C. Charpin, S. Garcia, C. Bouvier, B. Devictor, L. Andrac, R. Choux, and M. Lavaut (1997). E-cadherin quantitative immunocytochemical assays in breast carcinomas. J. Pathol. 181:294-300.

    PubMed  Google Scholar 

  58. W. Zschiesche, I. Schonborn, J. Behrens, K. Herrenknecht, F. Hartveit, P. Lilleng, and W. Birchmeier (1997). Expression of E-cadherin and catenins in invasive mammary carcinomas. Anticancer Res. 17:561-567.

    PubMed  Google Scholar 

  59. J. L. Jones, J. E. Royall, and R. A. Walker (1996). E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. Br. J. Cancer. 74:1237-1241.

    PubMed  Google Scholar 

  60. I. K. Bukholm, J. M. Nesland, and A. L. Borresen-Dale (2000). Re-expression of E-cadherin, α-catenin, and β-catenin, but not of γ-catenin, in tissue from breast cancer patients. J. Pathol. 190:15-19.

    PubMed  Google Scholar 

  61. I. Funke, S. Fries, M. Rolle, M. M. Heiss, M. Untch, H. Bohmert, F. W. Schildberg, and K. W. Jauch (1996). Comparative analysis of bone marrow micrometastases in breast and gastric cancer. Int. J. Cancer. 65:755-761.

    PubMed  Google Scholar 

  62. G. P. Cowley and M. E. Smith (1995). Modulation of E-cadherin expression and morphological phenotype in the intravascular component of adenocarcinomas. Int. J. Cancer 60:325-329.

    PubMed  Google Scholar 

  63. J. R. Graff, E. Gabrielson, H. Fujii, S. B. Baylin, and J. G. Herman (2000). Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J. Biol. Chem. 275:2727-2732.

    PubMed  Google Scholar 

  64. C. Charpin, S. Garcia, P. Bonnier, F. Martini, L. Andrac, R. Choux, M. N. Lavaut, and C. Allasia (1998). Reduced Ecadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival. Am. J. Clin. Pathol. 109:431-438.

    PubMed  Google Scholar 

  65. T. M. Maguire, S. G. Shering, E. W. McDermott, N. O'Higgins, J. J. Fennelly, J. Crown, and M. J. Duffy (1997). Assay of E-cadherin by ELISA in human breast cancers. Eur. J. Cancer 33:404-408.

    PubMed  Google Scholar 

  66. R. Heimann, F. Lan, R. McBride, and S. Hellman (2000). Separating favorable from unfavorable prognostic markers in breast cancer: The role of E-cadherin. Cancer Res. 60:298-304.

    PubMed  Google Scholar 

  67. K. S. Asgeirsson, J. G. Jonasson, L. Tryggvadottir, K. Olafsdottir, J. R. Sigurgeirsdottir, S. Invarsson, and H. M. Ogmundsdottir (2000). Altered expression of E-cadherin in breast cancer: Patterns, mechanisms and clinical significance. Eur. J. Cancer. 36:1098-1106.

    PubMed  Google Scholar 

  68. P. Lipponen, E. Saarelainen, S. Aaltomaa, and K. Syrjanen (1994). Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J. Pathol. 174:101-109.

    PubMed  Google Scholar 

  69. M. A. Gonzalez, S. E. Pinder, P. M. Wencyk, J. A. Bell, C. W. Elston, R. I. Nicholson, J. F. Robertson, R. W. Blamey, and I. O. Ellis (1999). An immunohistochemical examination of the expression of E-cadherin, α-and β/γ-catenins, and α2-and β1-integrins in invasive breast cancer. J. Pathol. 187:523-529.

    PubMed  Google Scholar 

  70. D. S. Tan, H. W. Potts, A. C. Leong, D. Skilton, W. H. Harris, R. D. Liebmann, and A. M. Hanby (1999). The biological and prognostic significance of cell polarity and E-cadherin in grade I infiltrating ductal carcinoma of the breast. J. Pathol. 189:20-27.

    PubMed  Google Scholar 

  71. D. L. Rimm, J. H. Sinard, and J. S. Morrow (1995). Reduced alpha-catenin and E-cadherin expression in breast cancer. Lab Invest. 72:506-512.

    PubMed  Google Scholar 

  72. I. K. Bukholm, J. M. Nesland, R. Karesen, U. Jacobsen, and A. L. Borresen-Dale (1998). E-cadherin and α-, β-, and γ-catenin protein expression in relation to metastasis in human breast carcinoma. J. Pathol. 185:262-266.

    PubMed  Google Scholar 

  73. J. M. Williams and C. W. Daniel (1983). Mammary ductal elongation: Differentiation of myoepithelium and basal lamina during branching morphogenesis. Devlop. Biol. 97:274-290.

    Google Scholar 

  74. J. Palacios, N. Benito, A. Pizarro, A. Suarez, J. Espada, A. Cano, and C. Gamallo (1995). Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. Am. J. Pathol. 146:605-612.

    PubMed  Google Scholar 

  75. G. Kremmidiotis, E. Baker, J. Crawford, H. J. Eyre, J. Nahmias, and D. F. Callen (1998). Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity. Genomics 49:467-471.

    PubMed  Google Scholar 

  76. S. W. Lee (1996). H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat. Med. 2:776-782.

    PubMed  Google Scholar 

  77. S. W. Lee, C. L. Reimer, D. B. Campbell, P. Cheresh, R. B. Duda, and O. Kocher (1998). H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo. Carcinogenesis 19:1157-1159.

    PubMed  Google Scholar 

  78. C. L. Sommers, E. P. Gelmann, R. Kemler, P. Cowin, and S. W. Byers (1994). Alterations in β-catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res. 54:3544-3552.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Margaret J. Wheelock.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wheelock, M.J., Soler, A.P. & Knudsen, K.A. Cadherin Junctions in Mammary Tumors. J Mammary Gland Biol Neoplasia 6, 275–285 (2001). https://doi.org/10.1023/A:1011319507155

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011319507155

Navigation